These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27632418)

  • 21. Exploration of Ultralarge Compound Collections for Drug Discovery.
    Warr WA; Nicklaus MC; Nicolaou CA; Rarey M
    J Chem Inf Model; 2022 May; 62(9):2021-2034. PubMed ID: 35421301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
    Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
    Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of new non-steroidal farnesoid X receptor modulators through 3D shape similarity search and structure-based virtual screening.
    Wang L; Si P; Sheng Y; Chen Y; Wan P; Shen X; Tang Y; Chen L; Li W
    Chem Biol Drug Des; 2015 Apr; 85(4):481-7. PubMed ID: 25228339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DOLINA--docking based on a local induced-fit algorithm: application toward small-molecule binding to nuclear receptors.
    Smieško M
    J Chem Inf Model; 2013 Jun; 53(6):1415-23. PubMed ID: 23725336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DrugSynthMC: An Atom-Based Generation of Drug-like Molecules with Monte Carlo Search.
    Roucairol M; Georgiou A; Cazenave T; Prischi F; Pardo OE
    J Chem Inf Model; 2024 Sep; 64(18):7097-7107. PubMed ID: 39249497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An extensive and diverse set of molecular overlays for the validation of pharmacophore programs.
    Giangreco I; Cosgrove DA; Packer MJ
    J Chem Inf Model; 2013 Apr; 53(4):852-66. PubMed ID: 23565904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CLEVER: pipeline for designing in silico chemical libraries.
    Song CM; Bernardo PH; Chai CL; Tong JC
    J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ring system-based chemical graph generation for de novo molecular design.
    Miyao T; Kaneko H; Funatsu K
    J Comput Aided Mol Des; 2016 May; 30(5):425-46. PubMed ID: 27299746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based computational approaches for small-molecule modulation of protein-protein interactions.
    Xu D; Wang B; Meroueh SO
    Methods Mol Biol; 2015; 1278():77-92. PubMed ID: 25859944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical space exploration with Molpher: Generating and assessing a glucocorticoid receptor ligand library.
    Agea MI; Čmelo I; Dehaen W; Chen Y; Kirchmair J; Sedlák D; Bartůněk P; Šícho M; Svozil D
    Mol Inform; 2024 Aug; 43(8):e202300316. PubMed ID: 38979783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Binding Pose and Modeled Structures on SVMGen and GlideScore Enrichment of Chemical Libraries.
    Xu D; Meroueh SO
    J Chem Inf Model; 2016 Jun; 56(6):1139-51. PubMed ID: 27154487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DrugSpaceX: a large screenable and synthetically tractable database extending drug space.
    Yang T; Li Z; Chen Y; Feng D; Wang G; Fu Z; Ding X; Tan X; Zhao J; Luo X; Chen K; Jiang H; Zheng M
    Nucleic Acids Res; 2021 Jan; 49(D1):D1170-D1178. PubMed ID: 33104791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversifying chemical libraries with generative topographic mapping.
    Lin A; Beck B; Horvath D; Marcou G; Varnek A
    J Comput Aided Mol Des; 2020 Jul; 34(7):805-815. PubMed ID: 31407224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Structure Similarity Search for Ligand-based Virtual Screening: Methods and Computational Resources.
    Yan X; Liao C; Liu Z; Hagler AT; Gu Q; Xu J
    Curr Drug Targets; 2016; 17(14):1580-1585. PubMed ID: 26521773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain.
    Unzue A; Xu M; Dong J; Wiedmer L; Spiliotopoulos D; Caflisch A; Nevado C
    J Med Chem; 2016 Feb; 59(4):1350-6. PubMed ID: 26043365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A virtual library of small molecules mimicking dipeptides.
    Lim VJY; Gerber HD; Schihada H; Trinh VT; Hilger D; Vázquez O; Kolb P
    Arch Pharm (Weinheim); 2024 May; 357(5):e2300636. PubMed ID: 38332463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.